From January 1, 2024 to March 31, 2024, the company has repurchased 5,198,975 shares, representing 0.42% for $400 million. With this, the company has completed the repurchase of 18,663,819 shares, representing 1.5% for $1,475.28 million under the buyback announced on February 25, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.9 USD | +0.27% | +0.53% | -16.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.18% | 84.37B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.